Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trans Sped is a leading Qualified Trust Service Provider (QTSP) that specializes in digital transformation and cybersecurity solutions for highly regulated industries. The company provides qualified electronic signatures, seals, and time stamps that are legally recognized across the European Union under eIDAS and in the United States. Within the life sciences sector, Trans Sped is a key provider of digital identity solutions compliant with FDA 21 CFR Part 11 and SAFE Identity standards. Their services enable pharmaceutical companies, CROs, and healthcare providers to securely digitize clinical trial workflows, regulatory submissions, and electronic health records. By offering cross-certified digital certificates, Trans Sped facilitates global interoperability and legal certainty for electronic documents in the biopharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trans Sped.